Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Stellantis
STLA
|
+$292M |
| 2 |
Constellation Brands
STZ
|
+$288M |
| 3 |
VMW
VMware, Inc
VMW
|
+$273M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
NiSource
NI
|
+$240M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.05B |
| 2 |
Apple
AAPL
|
+$1.81B |
| 3 |
UnitedHealth
UNH
|
+$1.01B |
| 4 |
Exxon Mobil
XOM
|
+$862M |
| 5 |
Tesla
TSLA
|
+$834M |
Sector Composition
| 1 | Technology | 27.58% |
| 2 | Consumer Discretionary | 11.38% |
| 3 | Healthcare | 10.81% |
| 4 | Financials | 10.71% |
| 5 | Communication Services | 6.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Forrester Research
FORR
$195M
| $442K | ﹤0.01% |
13,691
-158
| -1% | -$5.1K |
|
2627
Insteel Industries
IIIN
$749M
| $442K | ﹤0.01% |
15,890
+304
| +2% | +$8.46K |
|
2628
Open Lending Corp
LPRO
$252M
| $442K | ﹤0.01% |
62,804
-2,662
| -4% | -$18.7K |
|
2629
Methanex
MEOH
$3.04B
| $442K | ﹤0.01% |
9,500
+2,900
| +44% | +$135K |
|
2630
Corsair Gaming
CRSR
$948M
| $441K | ﹤0.01% |
24,067
+5,019
| +26% | +$92K |
|
|
CCVI
2631
DELISTED
Churchill Capital Corp VI
CCVI
| $441K | ﹤0.01% |
43,646
| – | – |
|
2632
Astria Therapeutics
ATXS
$419M
| $439K | ﹤0.01% |
+32,997
| New | +$439K |
|
2633
BioVie
BIVI
$14.1M
| $437K | ﹤0.01% |
541
+292
| +117% | +$236K |
|
|
AGS
2634
DELISTED
PlayAGS
AGS
| $435K | ﹤0.01% |
60,916
+21,481
| +54% | +$153K |
|
2635
Peapack-Gladstone Financial
PGC
$517M
| $435K | ﹤0.01% |
14,710
+7,746
| +111% | +$229K |
|
|
CS
2636
DELISTED
Credit Suisse Group
CS
| $435K | ﹤0.01% |
490,159
-182,269
| -27% | -$162K |
|
2637
iShares ESG Aware MSCI USA ETF
ESGU
$14.5B
| $434K | ﹤0.01% |
+4,800
| New | +$434K |
|
2638
Ryerson Holding
RYI
$723M
| $433K | ﹤0.01% |
11,897
+6,078
| +104% | +$221K |
|
2639
Leslie's
LESL
$62M
| $432K | ﹤0.01% |
39,297
-423,500
| -92% | -$4.66M |
|
2640
Summit Therapeutics
SMMT
$14.1B
| $432K | ﹤0.01% |
246,464
+232,605
| +1,678% | +$408K |
|
2641
Arlo Technologies
ARLO
$1.82B
| $431K | ﹤0.01% |
71,179
+1,573
| +2% | +$9.53K |
|
|
ATRI
2642
DELISTED
Atrion Corp
ATRI
| $431K | ﹤0.01% |
686
+321
| +88% | +$202K |
|
2643
Federated Hermes
FHI
$4.16B
| $430K | ﹤0.01% |
10,706
+9,606
| +873% | +$386K |
|
2644
SandRidge Energy
SD
$420M
| $430K | ﹤0.01% |
29,866
+8,008
| +37% | +$115K |
|
|
OKUR
2645
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.1M
| $430K | ﹤0.01% |
7,193
| – | – |
|
2646
CAE Inc
CAE
$8.47B
| $429K | ﹤0.01% |
18,963
+12,379
| +188% | +$280K |
|
2647
Kelly Services Class A
KELYA
$481M
| $428K | ﹤0.01% |
25,823
+1,012
| +4% | +$16.8K |
|
2648
Nine Energy Service
NINE
$30.5M
| $428K | ﹤0.01% |
+76,978
| New | +$428K |
|
|
NSTG
2649
DELISTED
NanoString Technologies, Inc.
NSTG
| $427K | ﹤0.01% |
43,209
+12,708
| +42% | +$126K |
|
2650
Fulgent Genetics
FLGT
$670M
| $426K | ﹤0.01% |
13,627
+3,765
| +38% | +$118K |
|